Cybin D/B/A Helus Pharma HELP

Full chart Compare
Set alert

Price alert · HELP

All alert types
9.03 USD +0.23 (+2.61%)

At closeNov 3, 2026, 5:27 PM EST

9.21 +0.18 +1.99%

After hours · Nov 3, 5:27 PM ET

8.94 Day range 9.57
3.76 52-week range 15.15
YTD
+10.39%
1 year
+34.18%

Revenue & Expenses

Other Income → Expenses: $29.54MExpenses → Selling, General & Admin: $88.24MExpenses → Research & Development: $54.91MIncome Tax Benefit → Expenses: $472.27KNet Loss → Expenses: $113.14MRevenue → Cost of Revenue: $472.27KOther Income$29.54MIncome Tax Benefit$472.27KNet Loss$113.14MCost of Revenue$472.27KExpenses$143.15MSelling, General & Admin$88.24MResearch & Development$54.91MRevenue$472.27K

Latest period ending Mar 31, 2026 · select a line to chart its full history

Annual income statement

HELP annual income statement
Fiscal yearFY 2026 Mar 31, 2026FY 2025 Mar 31, 2025FY 2024 Mar 31, 2024FY 2023 Mar 31, 2023FY 2022 Mar 31, 2022
142.59M103.13M78.84M51.52M63.84M
86.59M39.21M32.36M25.49M17.59M
45.14M32.63M32.59M21.34M28.22M
-142.59M-103.13M-78.84M-51.52M-63.84M
-148.00M-81.61M-78.08M-47.49M-67.63M
-148.00M-81.61M-78.08M-47.49M-67.63M
-107.24M-56.67M-57.41M-34.41M-53.68M
-148.00M-81.61M-78.08M-47.49M-67.63M
-4.25-4.04-9.41-9.90-15.20
-3.08-2.81-6.92-7.17-12.06
-4.25-4.04-9.41-9.90-15.20
-148.00M-81.61M-78.08M-47.49M-67.63M
-107.24M-56.67M-57.41M-34.41M-53.68M
34.80M20.22M8.30M4.88M4.40M
34.80M20.22M8.30M4.88M4.40M